LEVOCETIRIZINE DIHYDROCHLORIDE

Post-LOE

levocetirizine dihydrochloride

ANDAORALTABLET
Approved
Nov 2018
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
2

Clinical Trials (2)

NCT00628108Phase 3Completed

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 Months

Started Mar 2008
69 enrolled
Allergic RhinitisChronic Urticaria
NCT00619801Phase 3Completed

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Started Mar 2008
173 enrolled
Allergic RhinitisChronic Urticaria